Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Pulse Biosciences, Inc. (PLSE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "PULSE BIOSCIENCES, INC. Condensed Consolidated Balance Sheets June 30, December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 58,747 $ 61,139 Prepaid expenses and other current assets 1,211 1,008 Total current assets 59,958 62,147 Property and equipment, net 1,755 1,961 Intangible assets, net 2,218 2,551 Goodwill 2,791 2,791 Right-of-use assets 7,670 8,062 Other assets 365 365 Total assets $ 74,757 $ 77,877 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 1,794 $ 1,573 Accrued expenses 2,844 2,595 Lease liability, current 975 896 Related party note payable, current — 917 Total current liabilities 5,613 5,981 Lease liability, less current 8,644 9,144 Related party note payable, less current — 65,000 Total liabilities 14,257 80,125 Stockholders..."
07/20/2023 8-K Quarterly results
05/31/2023 SD Form SD - Specialized disclosure report:
05/30/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "PULSE BIOSCIENCES, INC. Condensed Consolidated Balance Sheets March 31, December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 54,098 $ 61,139 Prepaid expenses and other current assets 849 1,008 Total current assets 54,947 62,147 Property and equipment, net 1,865 1,961 Intangible assets, net 2,384 2,551 Goodwill 2,791 2,791 Right-of-use assets 7,869 8,062 Other assets 365 365 Total assets $ 70,221 $ 77,877 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 2,160 $ 1,573 Accrued expenses 3,091 2,595 Deferred revenue 4 — Lease liability, current 935 896 Related party note payable, current 801 917 Total current liabilities 6,991 5,981 Lease liability, less current 8,898 9,144 Related party note payable, current 65,000 65,000 Total liabilities 80,8..."
05/10/2023 SC 13D/A DUGGAN ROBERT W reports a 68.7% stake in Pulse Biosciences, Inc.
05/10/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
05/09/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Secu...
05/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment to Employment Agreement, between Kevin Danahy and Pulse Biosciences, Inc.",
"Amendment to Employment Agreement, between Darrin Uecker and Pulse Biosciences, Inc."
05/01/2023 8-K Quarterly results
04/14/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/14/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/21/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "First Amendment to Loan Agreement, between Pulse Biosciences, Inc. and Robert W. Duggan"
12/06/2022 8-K Quarterly results
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Quarterly results
09/23/2022 8-K Amended existing or entered into new employment agreement with an officer
Docs: "LOAN AGREEMENT",
"AMENDMENT TO EMPLOYMENT AGREEMENT",
"Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation"
08/10/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/10/2022 8-K Quarterly results
06/10/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/09/2022 8-K Quarterly results
06/03/2022 8-K Quarterly results
05/31/2022 SD Form SD - Specialized disclosure report:
05/23/2022 8-K Quarterly results
05/19/2022 8-K Quarterly results
05/19/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/13/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/11/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/11/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy